Inventor
CHUANG GWO-YU
US17 patents
Patents
17 patentsUS10017543B2Jul 10, 2018
Prefusion RSV F proteins and their use
US HEALTH26 citations92
US10035844B2Jul 31, 2018
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH6 citations83
US9695230B2Jul 4, 2017
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH9 citations83
US10400015B2Sep 3, 2019
Recombinant HIV-1 envelope proteins and their use
US HEALTH10 citations82
US11602559B2Mar 14, 2023
HIV-1 Env fusion peptide immunogens and their use
US HEALTH2 citations72
US11078239B2Aug 3, 2021
Prefusion PIV F immunogens and their use
US HEALTH1 citations72
US11459360B2Oct 4, 2022
Recombinant HIV-1 envelope proteins and their use
US HEALTH4 citations71
US11130785B2Sep 28, 2021
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US12458691B2Nov 4, 2025
HIV-1 ENV fusion peptide immunogens and their use
US HEALTH0 citations62
US12435113B2Oct 7, 2025
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US11845778B2Dec 19, 2023
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US12145968B2Nov 19, 2024
Recombinant HIV-1 envelope proteins and their use
US HEALTH0 citations61
US11981707B2May 14, 2024
Prefusion RSV F proteins and their use
US HEALTH0 citations61
US11136356B2Oct 5, 2021
Recombinant HIV-1 envelope proteins and their use
US HEALTH0 citations61
US12043660B2Jul 23, 2024
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use
US HEALTH0 citations56
US11236152B2Feb 1, 2022
Neutralizing antibodies to HIV-1 GP41 and their use
US HEALTH0 citations56
US10815295B2Oct 27, 2020
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH0 citations51